Akcea Therapeutics, Inc.

MA · United States · Reporting entity ID 100000476820

Total reported 2019–2025

$13.1M

#424 of 2,960 reporting companies — 0% of all reported industry payments

$2.30M in general payments across 9,245 records, plus $10.8M in research funding across 1,876 records.

How it breaks down

General payments $2,300,929

Research funding $10,793,630

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.